“It’s appalling the way AstraZeneca has been treated. I wouldn’t blame them if they were thoroughly fed up and decided to bow out of the covid vaccine business.”
That was the view from one of the biggest institutional investors in the UK.
It’s not a view the pharmaceutical giant and its talismanic boss Pascal Soriot would have expected to hear, having developed a safe, effective vaccine at breakneck speed, signing contracts…
Source link
